These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20010582)

  • 1. The changing economics of DNA synthesis.
    Carlson R
    Nat Biotechnol; 2009 Dec; 27(12):1091-4. PubMed ID: 20010582
    [No Abstract]   [Full Text] [Related]  

  • 2. Engineering a new business.
    May M
    Nat Biotechnol; 2009 Dec; 27(12):1112-20. PubMed ID: 20010588
    [No Abstract]   [Full Text] [Related]  

  • 3. Parts, property and sharing.
    Henkel J; Maurer SM
    Nat Biotechnol; 2009 Dec; 27(12):1095-8. PubMed ID: 20010583
    [No Abstract]   [Full Text] [Related]  

  • 4. Building outside of the box: iGEM and the BioBricks Foundation.
    Smolke CD
    Nat Biotechnol; 2009 Dec; 27(12):1099-102. PubMed ID: 20010584
    [No Abstract]   [Full Text] [Related]  

  • 5. The biotechnology bubble machine.
    Rasnick D
    Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic Biology in the Driving Seat of the Bioeconomy.
    Flores Bueso Y; Tangney M
    Trends Biotechnol; 2017 May; 35(5):373-378. PubMed ID: 28249675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited wealth.
    Wyke A
    Economist; 1988 Apr; 307():3-18. PubMed ID: 17256228
    [No Abstract]   [Full Text] [Related]  

  • 8. When the chips are down.
    Castellino AM
    Genome Res; 1997 Oct; 7(10):943-6. PubMed ID: 9331362
    [No Abstract]   [Full Text] [Related]  

  • 9. The genomics gamble.
    Cohen J
    Science; 1997 Feb; 275(5301):767-72. PubMed ID: 9036536
    [No Abstract]   [Full Text] [Related]  

  • 10. The economics of synthetic biology.
    Henkel J; Maurer SM
    Mol Syst Biol; 2007; 3():117. PubMed ID: 17551512
    [No Abstract]   [Full Text] [Related]  

  • 11. Our synthetic future.
    de S Cameron NM; Caplan A
    Nat Biotechnol; 2009 Dec; 27(12):1103-5. PubMed ID: 20010585
    [No Abstract]   [Full Text] [Related]  

  • 12. From synthetic biology to biohacking: are we prepared?
    Bennett G; Gilman N; Stavrianakis A; Rabinow P
    Nat Biotechnol; 2009 Dec; 27(12):1109-11. PubMed ID: 20010587
    [No Abstract]   [Full Text] [Related]  

  • 13. GM giants pair up to do battle.
    Mitchell P
    Nat Biotechnol; 2007 Jul; 25(7):695-6. PubMed ID: 17621277
    [No Abstract]   [Full Text] [Related]  

  • 14. Should moral objections to synthetic biology affect public policy?
    Kaebnick GE
    Nat Biotechnol; 2009 Dec; 27(12):1106-8. PubMed ID: 20010586
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomics and the world's economy.
    Enríquez J
    Science; 1998 Aug; 281(5379):925-6. PubMed ID: 9722465
    [No Abstract]   [Full Text] [Related]  

  • 16. How a bland statement sent stocks sprawling.
    Marshall E
    Science; 2000 Mar; 287(5461):2127. PubMed ID: 10744525
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology, bioremediation, and blue genes.
    Bialy H
    Nat Biotechnol; 1997 Feb; 15(2):110. PubMed ID: 9035117
    [No Abstract]   [Full Text] [Related]  

  • 18. Cures on the cob.
    Roosevelt M
    Time; 2003 May; 161(21):56-7. PubMed ID: 12800326
    [No Abstract]   [Full Text] [Related]  

  • 19. Minicrash tests biotechnology investors and companies as market fluctuates.
    Dorey E
    Nat Biotechnol; 1997 Dec; 15(13):1333. PubMed ID: 9415878
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech-biotech company mergers puzzle investors.
    Dorey E
    Nat Biotechnol; 1998 Jul; 16(7):616. PubMed ID: 9661187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.